Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.44 |
| ▸ | CPN1 | P15169 | 5/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL990377 | 0.82 | CPN1 (0.44) | CPB2CPN1TSHRHSD17B10 | |
| SCHEMBL32683934 | 0.82 | L3MBTL1 (0.43) | L3MBTL1CYP2D6ALDH1A1NPSR1TSHR | |
| SCHEMBL11374774 | 0.80 | L3MBTL1 (0.42) | CPB2CPN1L3MBTL1CYP2D6ALDH1A1 | |
| SCHEMBL32683476 | 0.78 | L3MBTL1 (0.41) | L3MBTL1CYP2D6ALDH1A1NPSR1TSHR | |
| SCHEMBL19926159 | 0.78 | L3MBTL1 (0.41) | L3MBTL1CYP2D6ALDH1A1NPSR1TSHR | |
| SCHEMBL1245653 | 0.78 | CYP2D6 (0.56) | L3MBTL1CYP2D6ALDH1A1NPSR1TSHR | |
| SCHEMBL772352 | 0.78 | CPB2 (0.41) | CPB2L3MBTL1CYP2D6ALDH1A1NPSR1 | |
| SCHEMBL1076982 | 0.77 | CPN1 (0.41) | CPB2CPN1ALDH1A1NPSR1TSHR | |
| SCHEMBL17730048 | 0.77 | SHBG (0.48) | L3MBTL1CYP2D6ALDH1A1NPSR1TSHR | |
| SCHEMBL32683404 | 0.77 | L3MBTL1 (0.40) | L3MBTL1CYP2D6ALDH1A1NPSR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1646612-A1 | PROCESSES FOR PREPARING MONTELUKAST SODIUM | Teva Pharmaceutical Industries Ltd (IL) | 2006-04-19 | — | — | EP | disclosed |
| WO-2005105751-A1 | PROCESSES FOR PREPARING MONTELUKAST SODIUM | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2005-11-10 | — | — | WO | disclosed |
| EP-0399818-B1 | Diarylstyrylquinoline diacids | MERCK FROSST CANADA INC (CA) | 1995-08-16 | — | — | EP | disclosed |
| US-5204358-A | Antiallergens; antiinflammatory agents; treatment of asthma, rhinitis, bronchitis and skin diseases | MERCK FROSST CANADA, INC. (CA) | 1993-04-20 | — | — | US | disclosed |
| US-5104882-A | Leukotriene antagonists | MERCK FROSST CANADA, INC. (CA) | 1992-04-14 | — | — | US | disclosed |
| EP-0399818-A1 | Diarylstyrylquinoline diacids | MERCK FROSST CANADA INC. (CA) | 1990-11-28 | — | — | EP | disclosed |